Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare cash
Cash and short-term investments held at the end of each period.
Prestige Consumer Healthcare's cash was $89.13M at Jun 30, 2026. For fiscal 2026 it was $63.87M, down 34.8% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $97.88M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $63.87M | -34.8% |
| FY2025 | Mar 31, 2025 | $97.88M | +110.6% |
| FY2024 | Mar 31, 2024 | $46.47M | -20.6% |
| FY2023 | Mar 31, 2023 | $58.49M | +115.2% |
| FY2022 | Mar 31, 2022 | $27.19M | -15.8% |
| FY2021 | Mar 31, 2021 | $32.30M | -65.9% |
| FY2020 | Mar 31, 2020 | $94.76M | +244.2% |
| FY2019 | Mar 31, 2019 | $27.53M | -15.4% |
| FY2018 | Mar 31, 2018 | $32.55M | -22.2% |
| FY2017 | Mar 31, 2017 | $41.86M | +53.7% |
| FY2016 | Mar 31, 2016 | $27.23M | +27.7% |
| FY2015 | Mar 31, 2015 | $21.32M | -24.8% |
| FY2014 | Mar 31, 2014 | $28.33M | +80.8% |
| FY2013 | Mar 31, 2013 | $15.67M | -17.6% |
| FY2012 | Mar 31, 2012 | $19.02M | +42.6% |
| FY2011 | Mar 31, 2011 | $13.33M | -67.6% |
| FY2010 | Mar 31, 2010 | $41.10M | +16.8% |
| FY2009 | Mar 31, 2009 | $35.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $89.13M | -36.1% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $63.87M | -34.8% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $62.37M | +22.6% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $119.11M | +131.1% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $139.50M | +307.2% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $97.88M | +110.6% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $50.87M | -20.0% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $51.54M | -14.2% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $34.26M | -37.2% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $46.47M | -20.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $63.62M | -26.3% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $60.07M | +41.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $54.58M | +52.2% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $58.49M | +115.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $86.36M | +310.9% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $42.44M | -0.9% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $35.87M | -78.1% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $27.19M | -15.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $21.02M | -66.2% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $42.82M | +61.0% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $163.62M | +182.4% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $32.30M | -65.9% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $62.10M | +117.2% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $26.60M | -4.7% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $57.94M | +99.5% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $94.76M | +244.2% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $28.59M | +15.9% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $27.91M | -24.4% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $29.04M | -15.3% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $27.53M | -15.4% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $24.67M | -45.6% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $36.91M | -14.1% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $34.27M | -22.4% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $32.55M | -22.2% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $45.38M | -28.3% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $42.98M | +41.1% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $44.14M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $41.86M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $63.29M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $30.46M | – |
See a number that looks wrong?